248 related articles for article (PubMed ID: 33606197)
1. Update on vertebral fractures in pituitary diseases: from research to clinical practice.
Carrone F; Ariano S; Piccini S; Milani D; Mirani M; Balzarini L; Lania AG; Mazziotti G
Hormones (Athens); 2021 Sep; 20(3):423-437. PubMed ID: 33606197
[TBL] [Abstract][Full Text] [Related]
2. New tools for bone health assessment in secreting pituitary adenomas.
Uygur MM; Frara S; di Filippo L; Giustina A
Trends Endocrinol Metab; 2023 Apr; 34(4):231-242. PubMed ID: 36869001
[TBL] [Abstract][Full Text] [Related]
3. Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients.
Apaydın T; Yavuz DG
J Endocrinol Invest; 2021 Aug; 44(8):1767-1773. PubMed ID: 33420960
[TBL] [Abstract][Full Text] [Related]
4. High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly.
Frara S; Melin Uygur M; di Filippo L; Doga M; Losa M; Santoro S; Mortini P; Giustina A
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2843-e2850. PubMed ID: 35349698
[TBL] [Abstract][Full Text] [Related]
5. High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.
Ferraù F; Giovinazzo S; Messina E; Tessitore A; Vinci S; Mazziotti G; Lania A; Granata F; Cannavò S
Endocrine; 2020 Jan; 67(1):172-179. PubMed ID: 31376100
[TBL] [Abstract][Full Text] [Related]
6. Looking at the spine in controlled Acromegaly.
Birtolo MF; Antonini S; Lania AG; Mazziotti G
Endocrine; 2023 Feb; 79(2):283-286. PubMed ID: 36574147
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to bone comorbidity in Cushing's disease: an update.
Frara S; di Filippo L; Doga M; Loli P; Casanueva FF; Giustina A
Pituitary; 2022 Oct; 25(5):754-759. PubMed ID: 35849272
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma.
Frara S; Uygur MM; Bolamperti F; di Filippo L; Doga M; Ferrari F; Losa M; Mortini P; Giustina A
Pituitary; 2024 May; ():. PubMed ID: 38802688
[TBL] [Abstract][Full Text] [Related]
9. Pituitary Diseases and Bone.
Mazziotti G; Frara S; Giustina A
Endocr Rev; 2018 Aug; 39(4):440-488. PubMed ID: 29684108
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
[TBL] [Abstract][Full Text] [Related]
11. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
[TBL] [Abstract][Full Text] [Related]
12. Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly.
Chiloiro S; Frara S; Gagliardi I; Bianchi A; Giampietro A; Medici M; Allora A; di Filippo L; Ambrosio MR; Pontecorvi A; Zatelli MC; De Marinis L; Giustina A
J Clin Endocrinol Metab; 2023 Dec; 109(1):e58-e68. PubMed ID: 37606222
[TBL] [Abstract][Full Text] [Related]
13. Bone histomorphometry in acromegaly patients with fragility vertebral fractures.
Dalle Carbonare L; Micheletti V; Cosaro E; Valenti MT; Mottes M; Francia G; Davì MV
Pituitary; 2018 Feb; 21(1):56-64. PubMed ID: 29214508
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of radiological vertebral fractures in patients with Klinefelter syndrome.
Vena W; Pizzocaro A; Indirli R; Amer M; Maffezzoni F; Delbarba A; Leonardi L; Balzarini L; Ulivieri FM; Ferlin A; Mantovani G; Lania AG; Ferrante E; Mazziotti G
Andrology; 2020 Nov; 8(6):1699-1704. PubMed ID: 32558374
[TBL] [Abstract][Full Text] [Related]
15. Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.
Ribeiro de Moura C; Campos Lopes S; Monteiro AM
Pituitary; 2022 Dec; 25(6):780-794. PubMed ID: 35867180
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study.
Mazziotti G; Battista C; Maffezzoni F; Chiloiro S; Ferrante E; Prencipe N; Grasso L; Gatto F; Olivetti R; Arosio M; Barale M; Bianchi A; Cellini M; Chiodini I; De Marinis L; Del Sindaco G; Di Somma C; Ferlin A; Ghigo E; Giampietro A; Grottoli S; Lavezzi E; Mantovani G; Morenghi E; Pivonello R; Porcelli T; Procopio M; Pugliese F; Scillitani A; Lania AG
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32511698
[TBL] [Abstract][Full Text] [Related]
17. Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.
Mazziotti G; Doga M; Frara S; Maffezzoni F; Porcelli T; Cerri L; Maroldi R; Giustina A
Endocrine; 2016 Apr; 52(1):103-10. PubMed ID: 26433736
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of morphometric vertebral fractures in osteoporotic patients in Greece: the Vertebral Integrity Assessment (VERTINAS) study.
Stathopoulos KD; Chronopoulos E; Galanos A; Kaskani E; Drakopoulou T; Ibro E; Tsekoura M; Kosmidis C
Arch Osteoporos; 2021 Nov; 16(1):165. PubMed ID: 34735660
[TBL] [Abstract][Full Text] [Related]
19. Pituitary diseases and bone.
Mazziotti G; Chiavistelli S; Giustina A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):171-80. PubMed ID: 25732653
[TBL] [Abstract][Full Text] [Related]
20. GH receptor isoforms and skeletal fragility in acromegaly.
Mormando M; Nasto LA; Bianchi A; Mazziotti G; Giampietro A; Pola E; Pontecorvi A; Giustina A; De Marinis L
Eur J Endocrinol; 2014 Aug; 171(2):237-45. PubMed ID: 24866575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
